menu
    • menu

    Company profile for Keros Therapeutics

    NEW Drugs in Dev: 7
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Keros focuses on the role of members of the TGF-β family of proteins in the development of blood cells, muscle and bone. Aged and damaged cells are routinely replaced by new cells in normally functioning organs. These new cells are derived from stem cells that have the ability to differentiate into cells with specialized function when appropriate signals are provided to maintain the homeostatic state of the tissue. Members of...
    Keros focuses on the role of members of the TGF-β family of proteins in the development of blood cells, muscle and bone. Aged and damaged cells are routinely replaced by new cells in normally functioning organs. These new cells are derived from stem cells that have the ability to differentiate into cells with specialized function when appropriate signals are provided to maintain the homeostatic state of the tissue. Members of the TGF-β family of proteins, including activins and bone morphogenetic proteins, provide the necessary signals for this process of self-renewal and repair.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Keros TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    Keros Therapeutics 99 Hayden Avenue Suite 120, Building E Lexington, MA 02421
    Telephone
    Telephone
    +1 (617) 314-6297
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.kerostx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/keros-therapeutics/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Clinical Outsourcing

    Clinical Outsourcing

    Not Confirmed

    envelop Contact Supplier

    Clinical Outsourcing

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Keros Therapeutics Appoints Charles Newton To Board Of Directors
    Keros Therapeutics Appoints Charles Newton To Board Of Directors

    26 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/26/3246046/0/en/Keros-Therapeutics-Appoints-Charles-Newton-to-its-Board-of-Directors.html

    GLOBENEWSWIRE
    26 Feb 2026
    Share Share
    Keros Therapeutics To Present At Healthcare Conferences
    Keros Therapeutics To Present At Healthcare Conferences

    18 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/18/3240601/0/en/Keros-Therapeutics-Announces-Participation-at-Upcoming-Healthcare-Conferences.html

    GLOBENEWSWIRE
    18 Feb 2026
    Share Share
    Keros Therapeutics Announces Final Results Of Tender Offer
    Keros Therapeutics Announces Final Results Of Tender Offer

    20 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/20/3192367/0/en/Keros-Therapeutics-Announces-Final-Results-of-Tender-Offer.html

    GLOBENEWSWIRE
    20 Nov 2025
    Share Share
    Keros Therapeutics Announces Preliminary Results Of Tender Offer
    Keros Therapeutics Announces Preliminary Results Of Tender Offer

    19 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/19/3190740/0/en/Keros-Therapeutics-Announces-Preliminary-Results-of-Tender-Offer.html

    GLOBENEWSWIRE
    19 Nov 2025
    Share Share
    Keros Therapeutics Reports Third Quarter 2025 Financial Results
    Keros Therapeutics Reports Third Quarter 2025 Financial Results

    05 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/05/3181905/0/en/Keros-Therapeutics-Reports-Third-Quarter-2025-Financial-Results.html

    GLOBENEWSWIRE
    05 Nov 2025
    Share Share
    Keros Therapeutics Starts Tender Offer To Buy Back $194.4M
    Keros Therapeutics Starts Tender Offer To Buy Back $194.4M

    20 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/20/3169169/0/en/Keros-Therapeutics-Commences-Issuer-Tender-Offer-to-Repurchase-up-to-194-4-Million-Shares.html

    GLOBENEWSWIRE
    20 Oct 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search